Core Insights - Chengdu XianDao Pharmaceutical Development Co., Ltd. aims to establish itself as a leading innovative biopharmaceutical company, focusing on new drug discovery and optimization, while integrating sustainable development practices into its operations [1][2][3] Company Overview - Chengdu XianDao is headquartered in Chengdu, China, with subsidiaries in Cambridge, UK, and Houston, USA, specializing in small molecule and nucleic acid drug discovery [2][3] - The company has developed a DNA-encoded compound library (DEL) technology platform, which is recognized as a global leader in the field [3][4] Sustainable Development Practices - The company has published its first sustainability report, outlining its commitment to environmental, social, and governance (ESG) principles, and aims to respond to stakeholder concerns [1][2] - Chengdu XianDao integrates sustainable development concepts into its operations, focusing on low-carbon transformation, talent development, and community welfare [2][3] Governance Structure - The company has established a robust governance framework to ensure transparency and compliance, including a board of directors with diverse expertise in the biopharmaceutical industry [5][6] - Chengdu XianDao has implemented various governance policies and procedures to enhance decision-making processes and risk management [5][6] Innovation and R&D - The company emphasizes innovation as a key driver for sustainable development, investing in technology upgrades and automation to enhance drug discovery capabilities [2][3] - Chengdu XianDao has a comprehensive training system to support employee development and foster a culture of innovation [2][5] Environmental Management - The company adheres to eco-friendly practices and has received ISO 9001 certification for its quality management system, demonstrating its commitment to environmental compliance [2][3] - Chengdu XianDao actively works to reduce its environmental impact through various measures, including resource efficiency and waste management [2][3] Stakeholder Engagement - The company has established a framework for ongoing communication with stakeholders, ensuring their concerns and expectations are addressed [7][8] - Chengdu XianDao identifies key issues through stakeholder feedback and integrates these insights into its strategic planning [7][8]
成都先导: 成都先导药物开发股份有限公司2024年可持续发展报告